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Objectives. The “Sick Lobe” hypothesis states that breast cancers evolve from entire lobes or portions of lobes of the breast where
initiation events have occurred early in development. The implication is that some cancers are isolated events and others are truly
multi-focal but limited to single lobar-ductal units. Methods. This is a single surgeon retrospective review of early stage breast
cancer lumpectomy patients treated from 1/2000 to 2/2005. Ductal endoscopy was used direct lumpectomy surgical margins by
deﬁning ductal anatomy and mapping proliferative changes within the sick lobe for complete excision. Results. Breast conservation
surgery for stage 0–2 breast cancer with an attempt to perform endoscopy in association with therapeutic lumpectomy was
performed in 554 patients (successful endoscopy in 465 cases). With an average followup of >5 years for the entire group, annual
hazard rate for local failure in traditional lumpectomy without ductal mapping was 0.97%/yr. and for lumpectomy with ductal
mapping and excision of entire sick lobe was 0.18%/yr. With endoscopy, 42% of patients were found to have extensive disease
within their “sick lobe.” Conclusions. Targeting breast cancer lumpectomy using endoscopy and excision of regional associated
proliferation seems associated with lower recurrence in this non-randomized series.
1.Introduction
The “Sick Lobe” hypothesis was proposed by Tibor Tot in
2005 [1]. His work was really a culmination of collecting
relevant clinical and pathologic observations of the last
century and a half. His ﬁrst observations and predictions
were based upon DCIS. The breast is deﬁned as a single
organ made of multiple lobes. Each lobe is identiﬁed by a
single oriﬁce on the nipple papilla connecting to branching
tree of ducts and hundreds to thousands of individual
lobules in the periphery. He proposed that for many cases
of DCIS (especially extensive ones) the initiating events of
carcinogenesis occurred perhaps as early as in the womb.
Then throughout life as the lobe both grew and contracted
from hormonal and other inﬂuences progression would
occur at varying rates in diﬀerent regions of the ductal
tree. This led to the situation of apparent multifocality
within the ductal tree and pathologic “skips” between DCIS
patches. With further whole mount examination, extensive
dissection of extensive intraductal component small invasive
cancer cases, and multifocal invasive cancers, the ﬁndings
support this theory [2–7]. Further molecular studies would
seem to indicate that serious adverse genetic events are
present throughout many ductal trees in what appears to
be histologically normal tissue surrounding known cancers
[8]. This is in direct conﬂict with older theories that the
initial events all occurred at the terminal ductal lobular
interface and spread pagetoid toward the nipple. The new
theory then proposes that simultaneous or asynchronous
malignant transformation occurs up and down ducts of
the entire lobe and not as a result of migration. It also
proposes that each lobe is relatively independent of the other
so that multifocality within the lobar unit is common but
multicentricity (simultaneous transformation in separate
lobes) is rare. This last prediction has certainly held true in
larger series of breast endoscopy where even widely separate
tumors within a single breast are connected to the same duct
system.
The problem comes in how do we turn this new theory
into something useful to the operative surgeon trying to do2 International Journal of Breast Cancer
the best job at breast conservation. The vast majority of early
stage tumors we treat seem to involve relative small region of
the ductal tree, and with current breast conservation surgery
andradiation,fewipsilateralnewtumorsappear.Ifthewhole
ductal tree was genetically predisposed, then it would seem
that we still should have more local failure events than we
currently encounter. The Tibor Tot version of the sick lobe
hypothesis would seem to indicate that a certain margin of
histologically normal tissue may be inadequate to prevent
recurrence. This clearly ﬂies in face of work such as Mel
Silverstein’s Van Nuys index where margin seems paramount
inpredictingrecurrence[9].Iffollowedtoitsfullconclusion,
Tot’s theory would have us excising the entire lobe (ductal
tree) associated with any new breast cancer. While feasible it
does seem too extensive and because of complex branching
technically diﬃcult for the average breast cancer.
From2000–2005,weperformedaseriesoflumpectomies
where the duct connecting the tumor with the nipple
was attempted to be identiﬁed. When the duct identiﬁed,
that duct was endoscoped to detect subclinical intraductal
proliferative disease [10]. As has been previously reported
this resulted in ﬁnding intraductal proliferative growths in
42% that extended beyond the image and clinical 1cm
planned excision margin. The ductal mapping revealed that
often cancers were relatively distally located and associated
proliferative disease seen endoscopically was limited to very
short segments of adjoining ducts. In the case of EIC, ducts
were extensively involved for long distances and had skips
of greater than 2cm commonly. Multifocal tumors arose in
separate regions of the ductal tree at varying rates. Using
the endoscopic ductal tree mapping of intraluminal disease,
we elected to remove all intraductal proliferative disease
associated with a known cancer independent of its histology
(i.e., DCIS, ADH, ALH, DH, etc.). This was done back to
at least a 1cm length of normal duct in the nippleward
direction. Once the duct was ﬁlled with tumor more distal
branches could not be endoscoped so the resection was
carried out in a pie-shaped wedge to the periphery to
encompass those additional portions of the ductal tree.
New proposed Modiﬁed Sick Lobe Hypothesis-Surgical
Practical Application.
We propose these changes/additions to the Tot “sick
Lobe” hypothesis to address surgical planning.
(1) Most breast cancers begin as isolated genetic events
in a single-stem cell during expansion of the ducto-
lobular tree.
(2) The extent of the ductal tree involvement is reﬂective
ofthe position of the stem cellwhereinitiation events
occurred. If occurring early and close to the nipple
the tree will have extensive involvement distally man-
ifested by large regions sharing abnormal genotype.
If occurring relatively late in the development of
the ductolobular tree, then regions derived from the
initiating stem cell will be peripheral and limited
within the tree. True pagetoid spread or spread by
random migration up and down the ducts would be
exceedingly rare.
(3) Surgical lumpectomy should be best deﬁned as the
adequate removal of the potions of the genetic tree
sharing the initiating genotype changes with the
known breast cancer. This approach should decrease
recurrence by eliminating metachrounous changes
within the same ducto-lobular tree.
This hypothesis could then be tested by examining
the local failure rates and patterns of local failures in the
endoscopically directed lumpectomies as compared to those
w h i c hw e r en o t .
2. Methods
This is a single surgeon review of patients treated at two
institutions (Johns Hopkins and University of Oklahoma)
from 1/2000 through 2/2005 with stages 0–2 breast cancer
with breast conservation without any neoadjuvant chemo-
or hormonal therapies.). All patients with prior periareolar
resections, prior open surgical biopsies, or large hematomas
associated with prior biopsy were not attempted. Otherwise
this series includes all those with small tumors (<3cm)
requesting conservation as previously reported. Each patient
had careful dekeratinization of the nipple in the operating
room and then underwent centripetal breast massage using
hand lotion. After the massage (which was also done
after lymphazurin injection if sentinel node was also being
performed), the retroareolar space was carefully compressed
to identify all ﬂuid producing oriﬁces in the nipple papilla.
The oriﬁce yielding ﬂuid closest to the position of the known
cancer or yielding lymphazurin in the case or peritumoral
injection was chosen for ductoscopy to identify the ductal
connection to the tumor and associated proliferative disease.
This was even done in cases of radiographic apparent
multifocality or multicentricity. Ductal anatomy was drawn
on the breast surface through the aid of transillumination
in a darkened room. Regions of intraductal ﬁlling defects
caused by epithelial proliferative growths were then marked
as well. Lumpectomies were designed to remove known
cancer and associated intraluminal growths as previously
discussed and in keeping with the new modiﬁed sick lobe
hypothesis.
3. Results
During this interval (2000–2005), there were 554 patients
with early-stage breast cancer in which endoscopy was
attempted (Table 1). Endoscopy was successfully completed
and identiﬁed correctly the duct connecting with the tumor
or immediate tumor region in 465 cases. In 16% of cases
where no ﬂuid producing duct was found or duct contained
no abnormalities and did not connect to tumor region,
lumpectomy was performed on the basis of clinical, radio-
graphic, and ultrasonographic guidance as is standard for
most breast surgeons. The average followup of these patients
was 5.9 years for the endoscopically directed lumpectomies
and 5.7 years for those not endoscopically directed (ranges
1 . 2 – 8y e a r s ) .T h ea n n u a lh a z a r dr a t ef o rl o c a lf a i l u r ew a s
0.97% for traditional lumpectomy and 0.18% for thoseInternational Journal of Breast Cancer 3





Stage 1 or 2 399 72%
# of successful endoscopies 465 84%
# BC with additional lesions 42.1%





nipple ward margin + 0.36%
Annual hazard rate for L/R recurrence
with endoscopic guidance 0.18%
Annual hazard rate for L/R recurrence
without endoscopic guidance 0.97%
who had endoscopically directed excision of tumor and
associated endoscopic lesions. This reaches statistical signif-
icance with the recurrence rate of 1.1% for endoscopically
directed lumpectomy and 5.6% for traditional lumpectomy
(P = 0.019; Chi Square, SPSS Ver.10 Chicago, IL). Diﬀuse
involvement of the lobe was deﬁned as extensive proliferative
changes seen endoscopically greater than 1cm from all
clinical, radiographic, and ultrasonographic evidences of
tumor. In some these involved the whole ductal tree but
in most were subsegmental in distribution. At the time
of these resections we had not anticipated the need to
document volume and weight so we do not have consistently
obtained information to compare these parameters in these
cases.
Since all patients were treated by NCCN guidelines or
on clinical trials, there were no patients who did not receive
radiation. All ER+ patients received hormonal therapy.
Event rates of local recurrence remain low enough that no
other treatment-related factors reach signiﬁcance. Local ER-
recurrences seem higher than ER-proportion in the entire
group but this also fails signiﬁcance.
4. Conclusions
The initial description of the “sick lobe” does ﬁt many
patientswithextensiveDCISormultifocalDCISandinvasive
disease [1]. Breast endoscopy strongly suggests that the
clinically relevant genetic changes may be more widespread
than initially radiographically appreciated changes but are
still often subsegmental within an individual lobe [10, 11].
Much has been argued over the beneﬁts of breast endoscopy
since so many of the intraluminal defects are not invasive
cancer or DCIS. Certainly the Cleveland Clinic experience
directly shows that these additional lesions would not
normallyraiseconcerniffoundatthemarginoftraditionally
performedlumpectomy[12].Asnotedpreviouslywetookan
alternate philosophical approach believing that regional pro-
liferative changes present close to a cancer and not elsewhere
were potentially sinister independent of the histopathologic
changes they showed. Our prior report conﬁrms that this
assumption was associated with dramatic improvements
in clear margins at ﬁrst resection. This can rightfully be
criticized in that these resections were bigger than those
of nonendoscopically directed lumpectomy so of course
marginswouldbebetter .H oweverifwearetrulyaﬀectingthe
natural history of breast cancer metachronous development
within a sick lobe, we should see much fewer ipsilateral
recurrences just as we have shown. Even though the absolute
number of events is small, we are struck by the fact that
contralateral breast cancers in these same patients seem to
be occurring at almost identical rates as ipsilateral events
in those patients with endoscopically directed proliferative
disease included lumpectomies. Further in these patients the
ipsilateral events seem randomly distributed and not clus-
tered in the same quadrant as the initial primary as seen in
nonendoscopically directed lumpectomy—either this series
or others. Several other ductoscopy-directed lumpectomy
series ﬁnd regional proliferative disease in patterns identical
to what we initially described in this series [11, 13–15].
Further we need to consider the classic idea of migration
of DCIS up and down the ducto-lobular tree. If shed cells
into the ductal ﬂuid are totipotent, then we would expect
that ductal installation of saline lavage or distending ﬂuids
associated with endoscopy would likely result in spreading of
disease. This should be manifested by increased local failure
events in the ipsilateral breast. Our data does not ﬁnd this.
Similarly researchers using ductal lavage in cancer patients
did not see increased local failures. One could argue that
such events are masked by the use of radiation for breast
conservation in these patients and that it is a valid possibility
for suppression of local recurrences. As more surgical
investigators become facile with ductal endoscopic mapping,
a clinical trial of endoscopically mapped lumpectomy
could test whether radiation therapy is still needed if we
actually can do an anatomically deﬁned lumpectomy. We
therefore ﬁnd that our follow-up data on ductoscopically
directed lumpectomy supports a new version of the “sick
lobe” hypothesis that directly addresses how surgeons
think and procede to surgical planning around the time of
lumpectomy. We view that breast cancer is a lobar disease
isolated to the section of the lobe where the initiation events
occurred and all subsequent outgrowth from those stem
cells. With this change, breast cancer may be isolated to
a distal branch of the ducto-lobular tree when initiation
events occurred late in lobar growth. These would be the
common tumors with little surrounding proliferative disease
and well treated by our current techniques. If these could be
better deﬁned by the genetic mapping of changes in ducts
in their region, simple excision or ablation of all genetically
abnormal epithelium of the duct without radiation might be
adequatefortheircontrol.Sometumorsdevelopfromearlier
initiation events but still isolated to larger segmental regions
within the ducto-lobular tree. Here excisions would need to
either be wider or have associated radiation to eliminate the
potential progression of genetically altered proliferative cells.4 International Journal of Breast Cancer
The extent of this abnormal proliferation within the segment
would determine also how much irradiation if any needed
(i.e., no radiation, partial breast irradiation, or whole breast
irradiation). Finally as in the classic Tibor Tot description,
the entire lobe is occasionally involved because the initiation
events occurred in some of the ﬁrst stem cells of the lobe
early in its development. Here either complete lobe excision
or whole breast treatment may be required. We agree with
Tibor Tot that true multicentricity of cancers developing in
diﬀering lobes of the same breast should be extremely rare
[5]. In fact we would propose given our preliminary data
that it should be no more common than synchronous or
metachronous contralateral breast cancers.
This new hypothesis then raises important clinically rele-
vantquestions.Canabetterlumpectomybeperformedwhen
guided by ductal anatomy and the plan to completely excise
proliferative changes sharing genetic signatures with the
primary tumor? Are our current tools adequate to embark
on an exploration of this hypothesis? If not, what needs to be
developed? Most submillimeter endoscopy systems currently
have limited biopsy capabilities. Can these be changed
or improved so that molecular mapping of the ductal
tree can be eﬃciently performed and a more biologically
appropriate surgical approach be taken to lumpectomy? If
an anatomic molecular mapped lumpectomy is feasible, can
we begin to consider elimination of radiation therapy in
early-stage breast cancer without LVI as an appropriate arm
in a clinical trial? As our molecular understanding and
genotyping of breast cancers become more commonplace,
we as surgeons need not to consider that these techniques are
onlywaystochoosebetteradjuvanttherapiesbutreassessour
technical approaches to breast cancer. We are still doing the
lumpectomytechniqueofBilrothinthemid1800’swithonly
more careful attention to histopathologic margin. It is time
for us to consider applying new and evolving breast cancer
biology information to improving the technical aspects of
local therapy.
Our data suggests that this new approach to lumpectomy
may be valid but can be criticized since increasing volume
of resection in certain cases would naturally be expected to
decrease recurrence. The Tot theory and our guidelines for
application to lumpectomy represent a major deviation from
traditional breast cancer biology theories. We encourage
others to consider these theoretical proposals and test them
against their own observations. The evolution of this new
sick lobe hypothesis and the ability to do real time ductal
mapping via ductoscopy should strongly motivate surgical
innovators to perform multicenter prospective randomized
trials to test the validity of this new theory and approach.
If accurate, this approach would fundamentally change local
therapy for breast cancer.
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